SCM:NYSEStellus Capital Investment Corporation Analysis
Data as of 2026-05-27 - not real-time
$9.16
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Stellus Capital Investment Corp (SCM) is trading below its short‑term moving averages, with technical indicators pointing to a bearish bias: the price sits under both the 20‑day and 50‑day SMA, MACD is in a bearish configuration and RSI hovers in the neutral zone. Fundamentally, the stock appears attractively priced, boasting a price‑to‑earnings multiple well beneath the industry average and a price‑to‑book ratio under one, suggesting a discount relative to peers. However, the company’s dividend yield is exceptionally high and the payout ratio exceeds 100%, raising concerns about the sustainability of the current distribution. Recent earnings commentary highlighted a decline in net asset value, elevated non‑accruals and a management outlook that the dividend will likely be reduced to better align with earnings. Volatility has been elevated over the past month and the historical maximum drawdown exceeds 40%, underscoring the stock’s price sensitivity. While cash flow remains positive and the balance sheet shows ample operating cash, the debt‑to‑equity ratio is extremely high, reflecting significant leverage typical of business development companies.
Given the juxtaposition of undervalued valuation metrics and the looming dividend sustainability issue, investors should weigh the upside from a potential price correction against the risk of continued earnings pressure and possible dividend cuts. The sector’s moderate risk profile and the company’s focus on North American middle‑market investments provide some stability, but the combination of high leverage, recent NAV contraction and a bearish technical picture suggest caution in the near term.
Given the juxtaposition of undervalued valuation metrics and the looming dividend sustainability issue, investors should weigh the upside from a potential price correction against the risk of continued earnings pressure and possible dividend cuts. The sector’s moderate risk profile and the company’s focus on North American middle‑market investments provide some stability, but the combination of high leverage, recent NAV contraction and a bearish technical picture suggest caution in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish technical positioning (price below SMAs, MACD negative)
- High dividend payout ratio indicating potential cut
- Elevated recent volatility and drawdown
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Undervalued valuation multiples relative to industry
- Improving cash flow generation but high leverage persists
- Management guidance pointing to dividend adjustment
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Fundamental discount (low PE and P/B) offers upside potential
- Stable asset base in middle‑market private debt with long‑term income
- Potential for dividend normalization improving sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth-6.60%
Profit Margin23.59%
P/E Ratio11.0
ROE6.44%
ROA4.32%
Debt/Equity170.30
P/B Ratio0.7
Op. Cash Flow$35.3M
Free Cash Flow$30.8M
Industry P/E16.6
Technical Analysis
TrendBearish
RSI43.2
Support$8.89
Resistance$9.95
MA 20$9.38
MA 50$9.42
MA 200$11.74
MACDBearish
VolumeIncreasing
Fear & Greed Index91.7
Valuation
Target Price$10.50
Upside/Downside14.63%
GradeUndervalued
TypeValue
Dividend Yield16.46%
Risk Assessment
Beta0.72
Volatility21.91%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.